VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Novo Nordisk A/S vs Wolters Kluwer N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisWolters Kluwer N.V.
WKL · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Wolters Kluwer N.V.'s moat claims, evidence, and risks.
View WKL analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 73 / 100 for Wolters Kluwer N.V.).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); Wolters Kluwer N.V. has 5 segments (26.8% in Health).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; Wolters Kluwer N.V. has 6 across 2.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Wolters Kluwer N.V.
Health
Clinical decision support and clinical drug information solutions (point-of-care) for healthcare providers
Global
Hospitals/health systems, clinicians, payers, and academic institutions
Software + expert content provider
26.8%
Side-by-side metrics
Moat coverage
Shared moat types
Novo Nordisk A/S strengths
Wolters Kluwer N.V. strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Wolters Kluwer N.V. segments
Full profile >Health
Oligopoly
Tax & Accounting
Oligopoly
Financial & Corporate Compliance
Oligopoly
Legal & Regulatory
Oligopoly
Corporate Performance & ESG
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.